Browsing by Author Goldhirsch, Aron (Prof)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 23  next >
Issue DateTitleAuthor(s)Citation
20072-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.Wilcken, Nicholas; Baselga, Jose (Prof); Bell, Richard (Prof); Bergh, Jonas (Prof); Cameron, David; Coleman, Robert; Dowsett, Mitch (Prof); Feyereislova, Andrea; Gelber, Richard D. (Prof); Gelmon, Karen (Prof); Goldhirsch, Aron (Prof); Guillaume, Sebastien; Harbeck, Nadia; Kaufmann, Manfred (Prof); Lopez, Roberto I; Mallmann, Peter (Prof); Mariani, Gabriella; Piccart-Gebhart, Martine J (Prof); Procter, Marion; Sanchez Rovira, Pedro; Smith, Ian (Prof); Untch, Michael (Prof); Wardley, Andrew; Wist, Erik (Prof); Western Clinical School: Medicine (Westmead)2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial., The Lancet, vol.369,(9555),2007,pp 29-36
2003Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trialCoates, Alan; Bonetti, Marco; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Nasi, M. Laura; O'Neill, Anne; Price, Karen N.; School of Public Health: Public HealthAdjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trial, Journal of the National Cancer Institute, vol.95,(24),2003,pp 1833-1846
2008Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trialsCoates, Alan; Clarke, M; Darby, S; Davies, C; Gelber, RD; Godwin, J; Goldhirsch, Aron (Prof); Gray, R; Peto, R; Pritchard, K I; Wood, W; School of Public Health: Public HealthAdjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials, The Lancet, vol.371, N/A, 2008,pp 29-40
2003Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVCoates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Lindtner, Jurji; Price, Karen N.; Rudenstam, Carl-Magnus; Senn, Hans-Jorg; School of Public Health: Public HealthAdjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV, Journal of Clinical Oncology, vol.21,(24),2003,pp 4517-4523
2015Adjuvant ovarian suppression in premenopausal breast cancerCoates, Alan; Bellet, Meritxell; Bonnefoi, Herve; Buchholz, Stefan; Burstein, Harold; Ciruelos, Eva; Climent, Miguel; Coleman, Richard; Colleoni, Marco; Da Prada, Gian; Davidson, Nancy; Fleming, Gini; Francis, Prudence; Gelber, Richard D. (Prof); Geyer, Charles; Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Ingle, J.; Kerbrat, Pierre; Lang, Istvan; Maibach, Rudolph; Martino, Silvana; Price, K. N; Rabaglio-Poretti, Manuela; Regan, Meredith; Ruepp, Barbara; Viale, Giuseppe; Walley, Barbara; Winer, EP; School of Public Health: Public HealthAdjuvant ovarian suppression in premenopausal breast cancer, The New England Journal of Medicine, vol.372, 5, 2015,pp 436-446
2001Adjuvant therapy for very young women with breast cancer: need for tailored treatments.Coates, Alan; Bryant,, J; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); Gray, R; Green, S; Yothers, G; School of Public Health: Public HealthAdjuvant therapy for very young women with breast cancer: need for tailored treatments., Journal of the National Cancer Institute, vol.30,(N/A),2001,pp 44-51
2013Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, Aron (Prof); Maibach, Rudolph; Pagani, Olivia; Price, Karen; Rabaglio, Manuela; Regan, Meredith; Ruepp, Barbara; Walley, B; School of Public Health: Public HealthAdjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials, The Breast, vol.22, 6, 2013,pp 1094-1100
2011Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 studyCoates, Alan; Chirgwin, Jacquie H; Colleoni, Marco; Forbes, John F.; Gelber, Richard D. (Prof); Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Lang, Istvan; Mauriac, L; Mouridsen, Henning; Paridaens, R.J.; Pienkowski, Tadeusz; Price, Karen N.; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, Beat; Wardley, Andrew; School of Public Health: Public HealthAnalyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study, Journal of Clinical Oncology, vol.29, 9, 2011,pp 1117-1124
2008Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study GroupCoates, Alan; Braye, Stephen; Brown, Robert; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Gusterson, Barry A.; Kovacs, Aniko; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Perin, Tiziana; Pillay, Komala; Price, Karen N.; Regan, Meredith M.; Rusca, Tiziana; Viale, Giuseppe; School of Public Health: Public HealthChemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study Group, Journal of Clinical Oncology, vol.26, 9, 2008,pp 1404-1410
2010Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast CancerCoates, Alan; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Gusterson, Barry; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen N.; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthClassical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer, Journal of Clinical Oncology, vol.28, 18, 2010,pp 2966-2973
2011Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialCoates, Alan; Aldridge, Julie; Bernhard, Jurg; Cardoso, Fatima; Gelber, RD; Goldhirsch, Aron (Prof); Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, K N; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.126, 1, 2011,pp 221-226
2003Comments on the St. Gallen Consensus 2003 on the primary therapy of early breast cancerCoates, Alan; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Senn, H.-J.; Thurlimann, B.; Wood, W. C.; School of Public Health: Public HealthComments on the St. Gallen Consensus 2003 on the primary therapy of early breast cancer, Breast, vol.12,(N/A),2003,pp 569-582
2003Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node statusCoates, Alan; Byrne, Michael J.; Castiglione-Gertsch, Monica; Collins, John; Cortes-Funes, Hernan; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Lindtner, Jurii; Litman, H; Maffini, Fausto; Martinez-Tello, Francisco J.; Masullo, Michele; Price, Karen; Simoncini, Edda; Spataro, Vito J.; Viale, Giuseppe; School of Public Health: Public HealthDecreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status, Cancer, vol.97,(7),2003,pp 1591-1600
2007Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); International, B e; Pagani, O.; Price, Karen N.; Simoncini, Edda; School of Public Health: Public HealthEffects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Annals of Oncology 2005, vol.18,(7),2007,pp 1177-1184
2006First-select the target: better choice of adjuvant treatments for breast cancer patients.Coates, Alan; Gelber, Richard D. (Prof); Glick, J. H.; Goldhirsch, Aron (Prof); Senn, Hans-Jorg; Thurlimann, B.; School of Public Health: Public HealthFirst-select the target: better choice of adjuvant treatments for breast cancer patients., Annals of Oncology 2005, vol.17,(12),2006,pp 1772-1776
2006Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Lindtner, Jurii; Murray, E.; Pagani, O.; Pestalozzi, B. C.; Price, K. N.; Simoncini, Edda; Zahrieh, David; School of Public Health: Public HealthIdentifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)., Annals of Oncology 2005, vol.17,(6),2006,pp 935-944
2009Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Collins, John; Crivellari, Diana; Forbes, John F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Price, Karen; Thurlimann, Beat; School of Public Health: Public HealthIs chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93., Breast Cancer Research and Treatment, vol.113,(N/A),2009,pp 137-144
2003Ki-67 expression in breast carcinomaCoates, Alan; Castiglione-Gertsch, Monica; Collins, John; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Gusterson, Barry; Murray, Susan; Price, Aaron; Trihia, Helen; School of Public Health: Public HealthKi-67 expression in breast carcinoma, Cancer, vol.97,(5),2003,pp 1321-1331
2006Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer - Results from International Breast Cancer Study Group Trials.Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Gelber, Richard D. (Prof); Gianni, Lorenzo; Goldhirsch, Aron (Prof); Holmberg, Stig B.; Li, Sigui; Panzini, Ilaria; Ravaioli, Alberto; School of Public Health: Public HealthOcular toxicity during adjuvant chemoendocrine therapy for early breast cancer - Results from International Breast Cancer Study Group Trials., Cancer, vol.106,(3),2006,pp 505-513
2012Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXCoates, Alan; O'Toole, Sandra; Castiglione-Gertsch, Monica; Gelber, Richard; Goldhirsch, Aron (Prof); Gusterson, Barry; Millar, E. K. A.; Molloy, T; Musgrove, Elizabeth A.; Regan, Meredith M.; Sun, Zhuoxin; Sutherland, Robert L.; Viale, Giuseppe; School of Public Health: Public Health; Central Clinical School: PathologyPrognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX, Breast Cancer Research, vol.14, 6, 2012,pp 1-12